Organ Transplantation 2024;15(3):377-382
doi:10.3969/j.issn.1674-7445.2024063
Highlights of clinical research on liver transplantation in China of 2023
Fangfei WANG 1 ; Qiang HE 1
Affiliations
Keywords
Liver transplantation; Rejection; Ischemia-reperfusion injury; Infection; Delayed graft function; Biliary complication; Hepatocellular carcinoma; Chronic kidney disease
Country
China
Language
Chinese
Abstract
As a mature organ transplantation, liver transplantation has become the optimal treatment for end-stage liver disease, which can improve the quality of life of recipients. However, liver transplantation still faces multiple challenges, such as rejection, infection, biliary complications, delayed graft function, ischemia-reperfusion injury, recurrence of hepatocellular carcinoma after liver transplantation, kidney-related diseases after transplantation, and donor shortage, etc., which remain to be improved and urgently resolved. With persistent attempts and experience accumulated by Chinese experts and scholars, these problems related to liver transplantation have been gradually resolved year by year. In 2023, liver transplantation teams in China have achieved a series of significant progresses in the field of clinical research. In this article, clinical frontiers and novel technological progresses in the field of liver transplantation in 2023 were reviewed, and the achievements of clinical liver transplantation in China in 2023 were summarized, aiming to provide novel ideas for promoting further development of liver transplantation in China.
备案号: 11010502037788, 京ICP备10218182号-8)